scispace - formally typeset
R

Ricardo Gandara

Researcher at University of Manchester

Publications -  8
Citations -  1194

Ricardo Gandara is an academic researcher from University of Manchester. The author has contributed to research in topics: Cancer cell & Stromal cell. The author has an hindex of 8, co-authored 8 publications receiving 1060 citations.

Papers
More filters
Journal ArticleDOI

Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.

TL;DR: The results directly show that breast cancer cells specifically induce the expression of MCT4 in cancer-associated fibroblasts, and provide the first evidence for the existence of a stromal-epithelial lactate shuttle in human tumors, analogous to the lactate shuttles that are essential for the normal physiological function of muscle tissue and brain.
Journal ArticleDOI

Using the “reverse Warburg effect” to identify high-risk breast cancer patients: Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers

TL;DR: The “Reverse Warburg Effect” or “parasitic” energy-transfer is a key determinant of poor overall patient survival and MCT4 inhibitors should be developed for the treatment of aggressive breast cancers, and possibly other types of human cancers.
Journal ArticleDOI

Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via "differentiation-based nano-therapy".

TL;DR: Graphene oxide is shown to be an effective non-toxic therapeutic strategy for the eradication of cancer stem cells, via differentiation-based nano-therapy and Mechanistically, it is presented evidence that GO exerts its striking effects on CSCs by inhibiting several key signal transduction pathways and thereby inducing CSC differentiation.
Journal ArticleDOI

Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin.

TL;DR: The beneficial anticancer effects of mitochondrial inhibitors (such as metformin) may be attributed to the induction of mitochondrial dysfunction in the epithelial cancer cell compartment, which identifies cancer cell mitochondria as a clear target for drug discovery and for novel therapeutic interventions.